Matches in SemOpenAlex for { <https://semopenalex.org/work/W4324018638> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- W4324018638 endingPage "2527" @default.
- W4324018638 startingPage "2521" @default.
- W4324018638 abstract "Immune checkpoint inhibitors (ICIs) have shown modest antitumor activity in unselected advanced sarcomas. Histology driven approach to patient selection is the current standard for off-label anti-programmed cell death 1 (PD1) immunotherapy use.We retrospectively reviewed the clinical characteristics and outcomes of patients with advanced sarcoma who were treated with off label anti-PD1 immunotherapy at our center.A total of 84 patients with 25 histological subtypes were included. Nineteen patients (23%) had a cutaneous primary tumor site. Eighteen patients (21%) were classified as having clinical benefit, including 1 patient with complete response, 14 with partial response, and 3 with stable disease lasting over 6 months with previously progressive disease. Cutaneous primary site location was associated with higher clinical benefit rate (58% vs. 11%, p < 0.001), longer median PFS (8.6 vs. 2.5 months, p = 0.003) and OS (19.0 vs. 9.2 months, p = 0.011), compared to non-cutaneous primary. Patients with histological subtypes that pembrolizumab is indicated per current National Comprehensive Cancer Network guidelines had modestly higher rate of clinical benefit versus other histologies, however, the difference was statistically insignificant (29% vs. 15%, p = 0.182) and no statistically significant difference in PFS or OS was observed between these groups. Immune-related adverse events were more frequently seen among patients with clinical benefit (72% vs. 35%, p = 0.007).Anti-PD1-based immunotherapy is highly efficacious in advanced sarcomas of cutaneous primary site. Cutaneous primary site location is a stronger predictor of ICI response than histologic subtype and should be accounted for in treatment guidelines and clinical trial design." @default.
- W4324018638 created "2023-03-14" @default.
- W4324018638 creator A5002234634 @default.
- W4324018638 creator A5013394493 @default.
- W4324018638 creator A5021389051 @default.
- W4324018638 creator A5026148638 @default.
- W4324018638 creator A5030256828 @default.
- W4324018638 creator A5034066580 @default.
- W4324018638 creator A5072672228 @default.
- W4324018638 creator A5078927422 @default.
- W4324018638 creator A5086051653 @default.
- W4324018638 date "2023-03-13" @default.
- W4324018638 modified "2023-09-25" @default.
- W4324018638 title "Anti-PD-1 therapy in advanced sarcomas: is cutaneous primary site a stronger predictor of response than histologic subtype?" @default.
- W4324018638 cites W2762797139 @default.
- W4324018638 cites W2773389902 @default.
- W4324018638 cites W2783070348 @default.
- W4324018638 cites W2783234388 @default.
- W4324018638 cites W2944423827 @default.
- W4324018638 cites W2967623209 @default.
- W4324018638 cites W2967881599 @default.
- W4324018638 cites W3005073090 @default.
- W4324018638 cites W3012656619 @default.
- W4324018638 cites W3087929049 @default.
- W4324018638 cites W3093855610 @default.
- W4324018638 cites W3099993684 @default.
- W4324018638 cites W3171636949 @default.
- W4324018638 cites W4200479769 @default.
- W4324018638 cites W4220757229 @default.
- W4324018638 cites W4220840640 @default.
- W4324018638 cites W4220979893 @default.
- W4324018638 cites W4297339120 @default.
- W4324018638 cites W4309168412 @default.
- W4324018638 doi "https://doi.org/10.1007/s00262-023-03387-6" @default.
- W4324018638 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36912932" @default.
- W4324018638 hasPublicationYear "2023" @default.
- W4324018638 type Work @default.
- W4324018638 citedByCount "0" @default.
- W4324018638 crossrefType "journal-article" @default.
- W4324018638 hasAuthorship W4324018638A5002234634 @default.
- W4324018638 hasAuthorship W4324018638A5013394493 @default.
- W4324018638 hasAuthorship W4324018638A5021389051 @default.
- W4324018638 hasAuthorship W4324018638A5026148638 @default.
- W4324018638 hasAuthorship W4324018638A5030256828 @default.
- W4324018638 hasAuthorship W4324018638A5034066580 @default.
- W4324018638 hasAuthorship W4324018638A5072672228 @default.
- W4324018638 hasAuthorship W4324018638A5078927422 @default.
- W4324018638 hasAuthorship W4324018638A5086051653 @default.
- W4324018638 hasBestOaLocation W43240186381 @default.
- W4324018638 hasConcept C121608353 @default.
- W4324018638 hasConcept C126322002 @default.
- W4324018638 hasConcept C142724271 @default.
- W4324018638 hasConcept C143998085 @default.
- W4324018638 hasConcept C197934379 @default.
- W4324018638 hasConcept C2777701055 @default.
- W4324018638 hasConcept C2778256501 @default.
- W4324018638 hasConcept C2778629024 @default.
- W4324018638 hasConcept C2778822529 @default.
- W4324018638 hasConcept C2779134260 @default.
- W4324018638 hasConcept C2780057760 @default.
- W4324018638 hasConcept C71924100 @default.
- W4324018638 hasConceptScore W4324018638C121608353 @default.
- W4324018638 hasConceptScore W4324018638C126322002 @default.
- W4324018638 hasConceptScore W4324018638C142724271 @default.
- W4324018638 hasConceptScore W4324018638C143998085 @default.
- W4324018638 hasConceptScore W4324018638C197934379 @default.
- W4324018638 hasConceptScore W4324018638C2777701055 @default.
- W4324018638 hasConceptScore W4324018638C2778256501 @default.
- W4324018638 hasConceptScore W4324018638C2778629024 @default.
- W4324018638 hasConceptScore W4324018638C2778822529 @default.
- W4324018638 hasConceptScore W4324018638C2779134260 @default.
- W4324018638 hasConceptScore W4324018638C2780057760 @default.
- W4324018638 hasConceptScore W4324018638C71924100 @default.
- W4324018638 hasIssue "7" @default.
- W4324018638 hasLocation W43240186381 @default.
- W4324018638 hasLocation W43240186382 @default.
- W4324018638 hasLocation W43240186383 @default.
- W4324018638 hasOpenAccess W4324018638 @default.
- W4324018638 hasPrimaryLocation W43240186381 @default.
- W4324018638 hasRelatedWork W2762797139 @default.
- W4324018638 hasRelatedWork W2777867648 @default.
- W4324018638 hasRelatedWork W2786497694 @default.
- W4324018638 hasRelatedWork W3029766637 @default.
- W4324018638 hasRelatedWork W3110914623 @default.
- W4324018638 hasRelatedWork W3153432702 @default.
- W4324018638 hasRelatedWork W3161613553 @default.
- W4324018638 hasRelatedWork W3215044659 @default.
- W4324018638 hasRelatedWork W4225414386 @default.
- W4324018638 hasRelatedWork W4225695268 @default.
- W4324018638 hasVolume "72" @default.
- W4324018638 isParatext "false" @default.
- W4324018638 isRetracted "false" @default.
- W4324018638 workType "article" @default.